Can Systemic Control Be Achieved in the Treatment of Oligometastatic Hepatocellular Cancer With Hepatic Artery Infusion Fluorouracil, Leucovorin, and Oxaliplatin Treatment?
- PMID: 35349330
- DOI: 10.1200/JCO.22.00047
Can Systemic Control Be Achieved in the Treatment of Oligometastatic Hepatocellular Cancer With Hepatic Artery Infusion Fluorouracil, Leucovorin, and Oxaliplatin Treatment?
Comment in
-
Reply to O. Sütcüoğlu et al.J Clin Oncol. 2022 Jun 10;40(17):1961-1962. doi: 10.1200/JCO.22.00378. Epub 2022 Mar 29. J Clin Oncol. 2022. PMID: 35349329 No abstract available.
Comment on
-
Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).J Clin Oncol. 2022 Feb 10;40(5):468-480. doi: 10.1200/JCO.21.01963. Epub 2021 Dec 14. J Clin Oncol. 2022. PMID: 34905388 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
